ATHENTIA NEXT Drug Patent Profile
When do Athentia Next patents expire, and when can generic versions of Athentia Next launch?
Athentia Next is a drug marketed by Aurobindo Pharma and is included in one NDA.
The generic ingredient in ATHENTIA NEXT is levonorgestrel. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Athentia Next
A generic version of ATHENTIA NEXT was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ATHENTIA NEXT?
- What are the global sales for ATHENTIA NEXT?
- What is Average Wholesale Price for ATHENTIA NEXT?
Summary for ATHENTIA NEXT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 71 |
| Patent Applications: | 3,942 |
| DailyMed Link: | ATHENTIA NEXT at DailyMed |
Pharmacology for ATHENTIA NEXT
| Drug Class | Progestin Progestin-containing Intrauterine System Progestin-containing Intrauterine Device |
| Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for ATHENTIA NEXT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | ATHENTIA NEXT | levonorgestrel | TABLET;ORAL | 206867-001 | Dec 8, 2015 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
